Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sets New 52-Week High – Here’s Why

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) hit a new 52-week high during trading on Monday . The company traded as high as $8.8275 and last traded at $8.80, with a volume of 138652 shares trading hands. The stock had previously closed at $7.94.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Zacks Research lowered Bayer Aktiengesellschaft from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Wall Street Zen upgraded Bayer Aktiengesellschaft from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, August 19th. Two equities research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Up 11.5%

The company has a market cap of $34.78 billion, a price-to-earnings ratio of -9.12, a price-to-earnings-growth ratio of 3.62 and a beta of 0.84. The stock has a 50-day simple moving average of $7.98 and a 200-day simple moving average of $7.80. The company has a current ratio of 1.13, a quick ratio of 0.73 and a debt-to-equity ratio of 1.04.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.